Learn more

EPIONTIS GMBH

Overview
  • Total Patents
    129
  • GoodIP Patent Rank
    16,241
  • Filing trend
    ⇧ 310.0%
About

EPIONTIS GMBH has a total of 129 patent applications. It increased the IP activity by 310.0%. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are REVERE BIOSENSORS LLC, CHRONIX BIOMEDICAL and BEIJING YIXIN BOCHUANG BIOLOGICAL TECHNOLOGY CO LTD.

Patent filings per year

Chart showing EPIONTIS GMBHs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Olek Sven 120
#2 Baron Udo 21
#3 Schulze Janika Josephin 7
#4 Tuerbachova Ivana 6
#5 Hoffmueller Ulrich 6
#6 Hoffmüller Ulrich 6
#7 Gardina Paul 4
#8 Hoffmuller Ulrich 3
#9 Türbachova Ivana 3
#10 Sven Olek 3

Latest patents

Publication Filing date Title
JP2020000242A Method for identifying quantitative cellular composition in biological sample
WO2020007951A1 Epigenetic method to detect and distinguish ipex and ipex-like syndromes, in particular in newborns
DE102018116353A1 Method for the detection and enumeration of epigenetic immune cells in human blood samples for immunodiagnostics and newborn screening
DE102018112644A1 CXCR3 as an epigenetic marker for the identification of inflammatory immune cells, in particular CD8 + memory T cells
DE102017126248A1 ERGIC1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mMDSCs)
DE102017125335A1 Amplicon region as an epigenetic marker for the identification of immune cells, especially non-classical monocytes
DE102017125150A1 Endosialin (CD248) as an epigenetic marker for the identification of immune cells, in particular naïver CD8 + T cells
DE102017125013A1 MCC as an epigenetic marker for the identification of immune cells, in particular basophilic granulocytes
DE102017125019A1 PDCD1 as an epigenetic marker for the identification of immune cells, in particular PD1 + cells
US2017233807A1 Epigenetic Markers for the Identification of Blood Sub-cells of Type 1
EP3360971A1 Improved method for epigenetic immune cell counting
GB201516972D0 LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells
GB201516975D0 PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes
GB201516971D0 MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells
EP3029150A1 Epigenetic method for the identification of follicular T-helper-(TFH-) cells
CA2904658A1 Method for identifying the quantitative cellular composition in a biological sample
EP2788510A1 Epigenetic marker for the identification of cd3cd4 positive t lymphocytes
GB201221133D0 Epigenetic method for the identification of subpopulations of CD8 and T lympocytes, in particular CD8 alpha and beta T lymphocytes
GB201117904D0 Epigenetic marker for the identification of il17 positive t cells in complex samples
WO2012045888A1 Method for determining cancer patient survival based on analyzing tumor-infiltrating overall t-lymphocytes